Fain J N, Wieser P B
J Biol Chem. 1975 Feb 10;250(3):1027-34.
In fat cells isolated from the parametrial adipose tissue of rats, the addition of purified adenosine deaminase increased lipolysis and cyclic adenosine 3':5'-monophosphate (cyclic AMP) accumulation. Adenosine deaminase markedly potentiated cyclic AMP accumulation due to norepinephrine. The increase in cyclic AMP due to adenosine deaminase was as rapid as that of theophylline with near maximal effects seen after only a 20-sec incubation. The increases in cyclic AMP due to crystalline adenosine deaminase from intestinal mucosa were seen at concentrations as low as 0.05 mug per ml. Further purification of the crystalline enzyme preparation by Sephadex G-100 chromatography increased both adenosine deaminase activity and cyclic AMP accumulation by fat cells. The effects of adenosine deaminase on fat cell metabolism were reversed by the addition of low concentrations of N6-(phenylisopropyl)adenosine, an analog of adenosine which is not deaminated. The effects of adenosine deaminase on cyclic AMP accumulation were blocked by coformycin which is a potent inhibitor of the enzyme. These findings suggest that deamination of adenosine is responsible for the observed effects of adenosine deaminase preparations. Protein kinase activity of fat cell homogenates was unaffected by adenosine or N6-(phenylisopropyl)adenosine. Norepinephrine-activated adenylate cyclase activity of fat cell ghosts was not inhibited by N6-(phenylisopropyl)adenosine. Adenosine deaminase did not alter basal or norepinephrine-activated adenylate cyclase activity. Cyclic AMP phosphodiesterase activity of fat cell ghosts was also unaffected by adenosine deaminase. Basal and insulin-stimulated glucose oxidation were little affected by adenosine deaminase. However, the addition of adenosine deaminase to fat cells incubated with 1.5 muM norepinephrine abolished the antilipolytic action of insulin and markedly reduced the increase in glucose oxidation due to insulin. These effects were reversed by N6-(phenylisopropyl)adenosine. Phenylisopropyl adenosine did not affect insulin action during a 1-hour incubation. If fat cells were incubated for 2 hours with phenylisopropyl adenosine prior to the addition of insulin for 1 hour there was a marked potentiation of insulin action. The potentiation of insulin action by prior incubation with phenylisopropyl adenosine was not unique as prostaglandin E1, and nicotinic acid had similar effects.
在从大鼠子宫旁脂肪组织分离出的脂肪细胞中,添加纯化的腺苷脱氨酶可增加脂肪分解以及环磷腺苷(cAMP)的积累。腺苷脱氨酶可显著增强去甲肾上腺素引起的cAMP积累。腺苷脱氨酶引起的cAMP增加与茶碱一样迅速,仅孵育20秒后就可见到接近最大的效应。来自肠黏膜的结晶腺苷脱氨酶在低至每毫升0.05微克的浓度下就能引起cAMP增加。通过葡聚糖G - 100柱层析对结晶酶制剂进行进一步纯化,可提高腺苷脱氨酶活性以及脂肪细胞中cAMP的积累。添加低浓度的N6 -(苯异丙基)腺苷(一种不能被脱氨的腺苷类似物)可逆转腺苷脱氨酶对脂肪细胞代谢的影响。腺苷脱氨酶对cAMP积累的影响可被助间型霉素阻断,助间型霉素是该酶的有效抑制剂。这些发现表明,腺苷的脱氨作用是腺苷脱氨酶制剂所观察到的效应的原因。脂肪细胞匀浆的蛋白激酶活性不受腺苷或N6 -(苯异丙基)腺苷的影响。N6 -(苯异丙基)腺苷不抑制脂肪细胞膜微粒体中去甲肾上腺素激活的腺苷酸环化酶活性。腺苷脱氨酶不改变基础或去甲肾上腺素激活的腺苷酸环化酶活性。脂肪细胞膜微粒体的环磷腺苷磷酸二酯酶活性也不受腺苷脱氨酶的影响。基础和胰岛素刺激的葡萄糖氧化受腺苷脱氨酶的影响很小。然而,在与1.5微摩尔去甲肾上腺素一起孵育的脂肪细胞中添加腺苷脱氨酶,可消除胰岛素的抗脂解作用,并显著降低胰岛素引起的葡萄糖氧化增加。这些效应可被N6 -(苯异丙基)腺苷逆转。苯异丙基腺苷在1小时孵育期间不影响胰岛素作用。如果在添加胰岛素1小时之前,脂肪细胞先与苯异丙基腺苷孵育2小时,则胰岛素作用会有显著增强。预先与苯异丙基腺苷孵育对胰岛素作用的增强并非独特现象,因为前列腺素E1和烟酸也有类似作用。